Interactions Between Astrocytes and Oligodendroglia in Myelin Development and Related Brain Diseases.

Astrocyte Glial network Myelination Neuroinflammation Oligodendroglia Synaptogenesis

Journal

Neuroscience bulletin
ISSN: 1995-8218
Titre abrégé: Neurosci Bull
Pays: Singapore
ID NLM: 101256850

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 05 04 2022
accepted: 08 08 2022
medline: 29 3 2023
pubmed: 13 11 2022
entrez: 12 11 2022
Statut: ppublish

Résumé

Astrocytes (ASTs) and oligodendroglial lineage cells (OLGs) are major macroglial cells in the central nervous system. ASTs communicate with each other through connexin (Cx) and Cx-based network structures, both of which allow for quick transport of nutrients and signals. Moreover, ASTs interact with OLGs through connexin (Cx)-mediated networks to modulate various physiological processes in the brain. In this article, following a brief description of the infrastructural basis of the glial networks and exocrine factors by which ASTs and OLGs may crosstalk, we focus on recapitulating how the interactions between these two types of glial cells modulate myelination, and how the AST-OLG interactions are involved in protecting the integrity of the blood-brain barrier (BBB) and regulating synaptogenesis and neural activity. Recent studies further suggest that AST-OLG interactions are associated with myelin-related diseases, such as multiple sclerosis. A better understanding of the regulatory mechanisms underlying AST-OLG interactions may inspire the development of novel therapeutic strategies for related brain diseases.

Identifiants

pubmed: 36370324
doi: 10.1007/s12264-022-00981-z
pii: 10.1007/s12264-022-00981-z
pmc: PMC10043111
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-552

Informations de copyright

© 2022. The Author(s).

Références

Neuroscientist. 2019 Aug;25(4):334-343
pubmed: 30122106
Cells. 2020 Apr 01;9(4):
pubmed: 32244730
Cells. 2020 Mar 03;9(3):
pubmed: 32138223
Glia. 2003 Nov;44(2):166-72
pubmed: 14515332
Adv Sci (Weinh). 2021 Aug;8(16):e2101181
pubmed: 34155833
Nat Neurosci. 2019 May;22(5):709-718
pubmed: 30988524
Front Mol Neurosci. 2018 May 18;11:162
pubmed: 29867353
Glia. 2010 Jul;58(9):1104-17
pubmed: 20468052
Acta Neuropathol. 2017 Sep;134(3):403-422
pubmed: 28631093
Int J Mol Sci. 2020 Oct 04;21(19):
pubmed: 33020408
J Cell Sci. 2016 May 1;129(9):1902-14
pubmed: 27006115
J Biosci. 2018 Dec;43(5):1055-1068
pubmed: 30541963
Mol Biol Rep. 2021 Jul;48(7):5473-5484
pubmed: 34312743
Cereb Cortex. 2018 Jun 1;28(6):2109-2117
pubmed: 28505229
Nature. 2012 May 27;486(7403):410-4
pubmed: 22722203
Metabolites. 2021 Aug 20;11(8):
pubmed: 34436491
Glia. 2018 Nov;66(11):2340-2352
pubmed: 30144323
Nat Neurosci. 2016 Sep;19(9):1210-1217
pubmed: 27455109
Acta Neuropathol. 2022 Feb;143(2):123-124
pubmed: 34910221
J Neurosci. 2021 Jun 9;41(23):4976-4990
pubmed: 33972402
Sci Rep. 2019 Jul 1;9(1):9437
pubmed: 31263155
Nat Med. 2018 Dec;24(12):1837-1844
pubmed: 30420755
Biochem Pharmacol. 2017 Oct 1;141:42-55
pubmed: 28522408
Neurosci Bull. 2021 Aug;37(8):1135-1146
pubmed: 34106403
Semin Cell Dev Biol. 2019 Nov;95:142-150
pubmed: 30951895
J Neurosci Res. 2005 Jan 1-15;79(1-2):2-10
pubmed: 15573408
Brain Res. 2016 Jun 15;1641(Pt A):139-148
pubmed: 26423932
Neurobiol Dis. 2011 Jun;42(3):506-13
pubmed: 21396451
Front Cell Neurosci. 2021 Jun 21;15:654284
pubmed: 34234647
Mol Neurobiol. 2018 Aug;55(8):6237-6249
pubmed: 29288338
J Neurosci Res. 1998 Oct 15;54(2):191-205
pubmed: 9788278
J Neurotrauma. 2011 Jun;28(6):1089-100
pubmed: 21309692
J Neurosci. 2011 May 18;31(20):7477-85
pubmed: 21593331
Glia. 2018 Dec;66(12):2589-2603
pubmed: 30325069
Glia. 2020 Jun;68(6):1201-1212
pubmed: 31868275
Neuron. 2019 Feb 6;101(3):459-471.e5
pubmed: 30654924
Science. 2016 Jan 22;351(6271):379-84
pubmed: 26798014
Front Cell Dev Biol. 2021 Jan 25;8:623771
pubmed: 33569385
Neurochem Res. 2020 Mar;45(3):620-629
pubmed: 31782103
J Tissue Eng Regen Med. 2018 Jan;12(1):e462-e472
pubmed: 28127945
J Neurosci. 2013 May 1;33(18):7985-96
pubmed: 23637189
Neurotherapeutics. 2018 Jul;15(3):554-577
pubmed: 29728852
Nat Rev Neurosci. 2020 Dec;21(12):682-694
pubmed: 33046886
Cell. 2021 Oct 14;184(21):5465-5481.e16
pubmed: 34582787
Cell Rep. 2021 Jan 12;34(2):108610
pubmed: 33440165
Brain Res. 2012 Dec 3;1487:88-98
pubmed: 22789907
Adv Neurobiol. 2019;23:311-329
pubmed: 31667813
FEBS Lett. 2021 May;595(10):1391-1410
pubmed: 33728650
Nature. 2021 Feb;590(7847):612-617
pubmed: 33361813
Front Neurol. 2020 Jul 31;11:703
pubmed: 32849190
Neurochem Int. 2014 Dec;78:18-27
pubmed: 25125369
Cells. 2021 Jul 15;10(7):
pubmed: 34359956
Pharmaceuticals (Basel). 2021 Jun 28;14(7):
pubmed: 34203192
Physiol Rev. 2006 Jul;86(3):1009-31
pubmed: 16816144
Brain Behav Immun. 2020 Feb;84:132-146
pubmed: 31785393
Cell. 2011 Mar 4;144(5):810-23
pubmed: 21376239
J Neurosci. 2011 Aug 31;31(35):12650-62
pubmed: 21880926
Cell. 2005 Feb 11;120(3):421-33
pubmed: 15707899
J Biol Chem. 2012 Nov 30;287(49):41432-45
pubmed: 23055518
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2160-2169
pubmed: 31932428
Front Cell Neurosci. 2015 Apr 24;9:155
pubmed: 25964740
Mol Neurobiol. 2014 Jun;49(3):1460-71
pubmed: 24395132
Neurosci Lett. 2020 Jan 10;715:134601
pubmed: 31693930
Biochem Biophys Res Commun. 2020 May 28;526(2):341-348
pubmed: 32220495
Glia. 2001 Dec;36(3):321-9
pubmed: 11746769
ACS Chem Neurosci. 2020 Sep 2;11(17):2717-2727
pubmed: 32667776
J Control Release. 2020 Jul 10;323:225-239
pubmed: 32289328
Neurosci Lett. 1984 Jun 29;47(3):271-6
pubmed: 6147800
PLoS One. 2014 Jul 31;9(7):e103174
pubmed: 25078775
Trends Cell Biol. 2013 Dec;23(12):644-51
pubmed: 23988427
Biol Rev Camb Philos Soc. 2019 Oct;94(5):1672-1684
pubmed: 31190441
Glia. 2019 Mar;67(3):467-481
pubmed: 30484905
Neurochem Int. 2020 Jun;136:104731
pubmed: 32201280
Glia. 2003 Dec;44(3):205-18
pubmed: 14603462
Cell Rep. 2021 Jan 19;34(3):108642
pubmed: 33472059
Nature. 2000 May 11;405(6783):187-91
pubmed: 10821275
Front Mol Neurosci. 2018 Nov 23;11:434
pubmed: 30532691
Neuron. 2021 Nov 3;109(21):3456-3472.e8
pubmed: 34506725
Dev Neurosci. 1998;20(4-5):291-9
pubmed: 9778565
Trends Neurosci. 2013 Jul;36(7):396-404
pubmed: 23639382
Transl Neurodegener. 2020 Nov 26;9(1):42
pubmed: 33239064
Cold Spring Harb Perspect Biol. 2015 Feb 06;7(9):a020370
pubmed: 25663667
J Neurosci. 2012 May 30;32(22):7499-518
pubmed: 22649229
J Neuroimmunol. 2010 Dec 15;229(1-2):180-91
pubmed: 20832870
Exp Gerontol. 2017 Aug;94:89-92
pubmed: 28167236
ASN Neuro. 2020 Jan-Dec;12:1759091420962681
pubmed: 32993319
J Neurosci. 2012 Apr 4;32(14):4841-7
pubmed: 22492039
Curr Opin Neurobiol. 2018 Dec;53:90-95
pubmed: 29975877
Handb Clin Neurol. 2014;122:15-58
pubmed: 24507512
Nat Commun. 2019 Aug 29;10(1):3887
pubmed: 31467299
Neuron. 2008 Mar 27;57(6):883-93
pubmed: 18367089
Trends Immunol. 2007 Jan;28(1):12-8
pubmed: 17129764
Nat Neurosci. 2021 Dec;24(12):1686-1698
pubmed: 34782794
Dev Neurobiol. 2017 May;77(5):625-642
pubmed: 27314460
Curr Opin Neurobiol. 2013 Dec;23(6):914-20
pubmed: 23831087
Nature. 2012 Jul 26;487(7408):443-8
pubmed: 22801498
Glia. 2006 Nov 15;54(7):716-725
pubmed: 17006900
Cell Stem Cell. 2021 May 6;28(5):923-937.e4
pubmed: 33675690
Neuroscience. 2021 Feb 21;456:71-84
pubmed: 32224231
Cells. 2021 Apr 23;10(5):
pubmed: 33922642
PLoS Biol. 2020 Dec 22;18(12):e3000621
pubmed: 33351792
Neuroscience. 2020 Jul 15;439:163-180
pubmed: 31349008
Cell Death Dis. 2020 Jan 6;11(1):9
pubmed: 31907363
CNS Neurosci Ther. 2018 Feb;24(2):126-134
pubmed: 29205833
Neuron. 2018 Aug 22;99(4):689-701.e5
pubmed: 30078577
Nat Immunol. 2013 Mar;14(3):254-61
pubmed: 23291597
J Physiol. 2017 Mar 15;595(6):1903-1916
pubmed: 27381164
Nature. 2013 Dec 19;504(7480):394-400
pubmed: 24270812
Nat Commun. 2021 Sep 30;12(1):5740
pubmed: 34593806
Neuron. 2021 Aug 18;109(16):2545-2555.e7
pubmed: 34245686
Glia. 2015 Jun;63(6):1021-35
pubmed: 25739948
Cold Spring Harb Perspect Biol. 2015 Feb 13;7(12):
pubmed: 25680832
Glia. 2015 Aug;63(8):1320-9
pubmed: 25963996
Glia. 2020 Sep;68(9):1692-1728
pubmed: 31958188
J Neurosci Res. 2008 Oct;86(13):2857-66
pubmed: 18500760
Int J Mol Sci. 2020 Nov 20;21(22):
pubmed: 33233502
Trends Neurosci. 1999 May;22(5):208-15
pubmed: 10322493
J Clin Invest. 2013 Feb;123(2):782-6
pubmed: 23281396
J Neurosci. 2011 Jan 12;31(2):538-48
pubmed: 21228163

Auteurs

Xuelian Hu (X)

School of Medicine, Chongqing University, Chongqing, 400030, China.
Department of Histology and Embryology, Chongqing Key Laboratory of Neurobiology, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, Third Military Medical University, Chongqing, 400038, China.

Guangdan Yu (G)

Department of Histology and Embryology, Chongqing Key Laboratory of Neurobiology, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, Third Military Medical University, Chongqing, 400038, China.

Xiang Liao (X)

School of Medicine, Chongqing University, Chongqing, 400030, China.

Lan Xiao (L)

School of Medicine, Chongqing University, Chongqing, 400030, China. xiaolan35@hotmail.com.
Department of Histology and Embryology, Chongqing Key Laboratory of Neurobiology, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, Third Military Medical University, Chongqing, 400038, China. xiaolan35@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH